YY1 Lactylation Elicits CARD9 Deficiency in Dendritic Cells Promoting Pancreatic Cancer Immune Escape
Lingyan Ding, Cheng Tian, Yiting Feng, Ruochen Xu, Senlin Li, Mengzhu Zheng, Xiaoyan Wang, Qianqian Xu, Ming Xiang · 2026
Read YY1 Lactylation Elicits CARD9 Deficiency in Dendritic Cells Promoting Pancreatic Cancer Immune Escape by Lingyan Ding, Cheng Tian, Yiting Feng, Ruochen Xu, Senlin Li, Mengzhu Zheng, Xiaoyan Wang, Qianqian Xu, Ming Xiang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13215062.txt.
Description
Pancreatic cancer shields itself from the immune system by disabling dendritic cells, the sentries that wake killer T cells. Lingyan Ding and co-authors trace that sabotage to a protein in the sentries: CARD9, whose loss they had tied to worse disease. In tumors, CARD9 falls as the cancer advances, and cancer cells push it down in dendritic cells, blunting their maturation and T cell attack.
The repressor is YY1, a transcription factor that binds the CARD9 gene's promoter and shuts it. Tumor-made lactate tags YY1 with a lactyl group at one lysine, a mark written by p300 and erased by HDAC2. The tag sends YY1 into the nucleus, tightens its grip on the promoter, and shields it from destruction, locking CARD9. Restoring CARD9 reversed the suppression. The authors name this lactate-to-YY1-to-CARD9 chain a driver of immune escape and a drug target.
Catalog record
| CREATOR | Lingyan Ding, Cheng Tian, Yiting Feng, Ruochen Xu, Senlin Li, Mengzhu Zheng, Xiaoyan Wang, Qianqian Xu, Ming Xiang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |